11 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28186757	66	Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure-Activity Relationship.	European Institute of Oncology
28186755	85	Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 1: High-Throughput Screening and Preliminary Exploration.	European Institute of Oncology
28065500	8	Activation of lysine-specific demethylase 1 inhibitor peptide by redox-controlled cleavage of a traceless linker.	Nagoya City University
26702542	59	Discovery of a Novel Inhibitor of Histone Lysine-Specific Demethylase 1A (KDM1A/LSD1) as Orally Active Antitumor Agent.	European Institute of Oncology
24883177	10	Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1.	Medical University of South Carolina
25580204	10	3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.	Medical University of South Carolina
25585008	28	Further insights into the SAR of ?-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A.	University of Parma
29459279	10	Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis.	Medical University of South Carolina